
Folic acid-like drug modifies DNA in aggressive brain tumours: Study
Research showed for the first time that the DNA methylome of these brain tumours can be reprogrammed. The study was published recently in the medical journal “Cancer Research Communications”. Stephen Clark — MD, PhD, and a neuro-oncologist at Vanderbilt-Ingram Cancer Centre — who is the study’s corresponding and lead author, said that this is the first time DNA methylome reprogramming has occurred with any solid human tumour.